Related Experiment Video
Updated: Nov 19, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology
Masahide Harada1, Stanley Nattel2
1Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake 4701192, Japan.
Insights
Inflammation and fibrosis drive atrial fibrillation by promoting cardiac remodeling and conduction issues. Targeting these processes may offer new therapeutic strategies for atrial fibrillation.
Area of Science:
- Cardiology
- Pathophysiology
- Fibrosis Research
Background:
- Atrial fibrillation (AF) pathophysiology involves inflammation and fibrosis.
- Atrial fibrosis disrupts normal heart rhythm by causing conduction disturbances.
- Systemic inflammation activates cardiac fibroblasts, leading to fibrosis.
Purpose of the Study:
- To review current knowledge on inflammation and fibrosis in atrial fibrillation.
- To highlight the interplay between inflammation and fibrosis in AF progression.
- To discuss the potential of targeting inflammation and fibrosis as therapeutic strategies for AF.
Main Methods:
- Literature review of existing research on atrial fibrillation, inflammation, and fibrosis.
- Analysis of the mechanisms linking inflammatory mediators to cardiac fibroblast activation.
- Synthesis of data on the role of fibrosis in atrial remodeling and AF maintenance.
Main Results:
- Inflammation and fibrosis are key components in the pathophysiology of atrial fibrillation.
- A complex interplay exists between inflammation and fibrosis, creating a cycle of atrial remodeling.
- This cycle contributes to the maintenance of atrial fibrillation and increases thrombogenicity.
Conclusions:
- Inflammation and fibrosis are critical targets for managing atrial fibrillation.
- Understanding the interplay between these factors is crucial for developing effective therapies.
- Targeting inflammation and fibrosis holds promise for treating atrial fibrillation and reducing associated risks.
Abstract:
Inflammation and fibrosis have been implicated in the pathophysiology of atrial fibrillation. Atrial fibrosis causes conduction disturbances and is a central component of atrial remodeling in atrial fibrillation. Cardiac fibroblasts, the cells responsible for fibrosis formation, are activated by inflammatory mediators and growth factors associated with systemic inflammatory conditions. Thus, inflammation contributes to atrial fibrosis; the complex interplay of these maladaptive components creates a vicious cycle of atrial remodeling progression, maintaining atrial fibrillation and increasing thrombogenicity. This review provides up-to-date knowledge regarding inflammation and fibrosis in atrial fibrillation pathophysiology and their potential as therapeutic targets.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Pericarditis I: Introduction
Clot Retraction and Fibrinolysis
Atherosclerosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins

